Xiaosong Chen

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Topics

Positive Breast Cancer

Randomized Controlled Trial

Top Venues

Breast cancer research and treatment

European radiology

Journal of breast cancer

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Liangqiang Li, Jing Yu, Kunwei Shen, Xiaosong Chen
The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients. Journal of breast cancer (2024)
Yiwei Tong, Zhaoyu Hu, Haoyu Wang, Jiahui Huang, Ying Zhan, Weimin Chai, Yinhui Deng, Ying Yuan, Kunwei Shen, Yuanyuan Wang, Xiaosong Chen, Jinhua Yu
Anti-HER2 therapy response assessment for guiding treatment (de-)escalation in early HER2-positive breast cancer using a novel deep learning radiomics model. European radiology (2024)
Yiwei Tong, Zhaoyu Hu, Haoyu Wang, Jiahui Huang, Ying Zhan, Weimin Chai, Yinhui Deng, Ying Yuan, Kunwei Shen, Yuanyuan Wang, Xiaosong Chen, Jinhua Yu
Anti-HER2 therapy response assessment for guiding treatment (de-)escalation in early HER2-positive breast cancer using a novel deep learning radiomics model. European radiology 34 (8) (2024)
Yiwei Tong, Zhaoyu Hu, Haoyu Wang, Jiahui Huang, Ying Zhan, Weimin Chai, Yinhui Deng, Ying Yuan, Kunwei Shen, Yuanyuan Wang, Xiaosong Chen, Jinhua Yu
Anti-HER2 therapy response assessment for guiding treatment (de-)escalation in early HER2-positive breast cancer using a novel deep learning radiomics model. European radiology 34 (8) (2024)
Liangqiang Li, Jing Yu, Kunwei Shen, Xiaosong Chen
The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients. Journal of breast cancer 27 (3) (2024)
Liangqiang Li, Jing Yu, Kunwei Shen, Xiaosong Chen
The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients. Journal of breast cancer 27 (3) (2024)
Yiwei Tong, Zhaoyu Hu, Haoyu Wang, Jiahui Huang, Ying Zhan, Weimin Chai, Yinhui Deng, Ying Yuan, Kunwei Shen, Yuanyuan Wang, Xiaosong Chen, Jinhua Yu
Anti-HER2 therapy response assessment for guiding treatment (de-)escalation in early HER2-positive breast cancer using a novel deep learning radiomics model. European radiology 34 (8) (2024)
Liangqiang Li, Jing Yu, Kunwei Shen, Xiaosong Chen
The 21-Gene Recurrence Score Assay Improved Multidisciplinary Treatment Compliance in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: An Analysis of 2,323 Patients. Journal of breast cancer 27 (3) (2024)
Yiwei Tong, Zhaoyu Hu, Haoyu Wang, Jiahui Huang, Ying Zhan, Weimin Chai, Yinhui Deng, Ying Yuan, Kunwei Shen, Yuanyuan Wang, Xiaosong Chen, Jinhua Yu
Anti-HER2 therapy response assessment for guiding treatment (de-)escalation in early HER2-positive breast cancer using a novel deep learning radiomics model. European radiology 34 (8) (2024)
Yanting Shih, Shile Chen, Jie Huang, Yongheng Chen, Zicong Zhu, Qian Zhao, Xiaoqing Zhao, Feng Xue, Jie Xiang, Xiaosong Chen, Xuemei Zhu, Meng Pan, Jun Wu, Jie Zheng, Hao Li, Hua Cao
Serum level of galectin-9 as a potential biomarker for high risk of malignancy in dermatomyositis. Rheumatology (Oxford, England) (2023)
Renhong Huang, Zheng Wang, Jin Hong, Jiayi Wu, Ou Huang, Jianrong He, Weiguo Chen, Yafen Li, Xiaosong Chen, Kunwei Shen
Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy. Cell death & disease 14 (10) (2023)
Yanting Shih, Mengya Chen, Shile Chen, Szeman Cheung, Yongheng Chen, Qian Zhao, Ke Xue, Feng Xue, Xiaosong Chen, Min Zhou, Hao Li, Jie Zheng, Yunchen Le, Hua Cao
Enhanced tryptophan-kynurenine metabolism via indoleamine 2,3-dioxygenase 1 induction in dermatomyositis. Clinical rheumatology 41 (10) (2022)
Jiahui Huang, Yiwei Tong, Jin Hong, Ou Huang, Jiayi Wu, Jianrong He, Weiguo Chen, Yafen Li, Xiaosong Chen, Kunwei Shen
Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial. Breast cancer research and treatment 197 (3) (2022)
Weiqi Gao, Shuangshuang Lu, Yufei Zeng, Xiaosong Chen, Kunwei Shen
Axilla lymph node dissection can be safely omitted in patients with 1-2 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis. Breast cancer research and treatment 196 (1) (2022)
Jiahui Huang, Yiwei Tong, Jin Hong, Ou Huang, Jiayi Wu, Jianrong He, Weiguo Chen, Yafen Li, Xiaosong Chen, Kunwei Shen
Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial. Breast cancer research and treatment 197 (3) (2022)
Jiahui Huang, Yiwei Tong, Jin Hong, Ou Huang, Jiayi Wu, Jianrong He, Weiguo Chen, Yafen Li, Xiaosong Chen, Kunwei Shen
Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial. Breast cancer research and treatment (2022)
Jiahui Huang, Yiwei Tong, Jin Hong, Ou Huang, Jiayi Wu, Jianrong He, Weiguo Chen, Yafen Li, Xiaosong Chen, Kunwei Shen
Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial. Breast cancer research and treatment 197 (3) (2022)
Jin Hong, Weiwei Rui, Xiaochun Fei, Xiaosong Chen, Kunwei Shen
Association of tumor-infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer. Cancer medicine 10 (22) (2021)
Yujie Lu, Yiwei Tong, Jiahui Huang, Lin Lin, Jiayi Wu, Xiaochun Fei, Xiaosong Chen, Kunwei Shen
Diverse Distribution and Gene Expression on the 21-Gene Recurrence Assay in Breast Cancer Patients with Locoregional Recurrence Versus Distant Metastasis. Cancer management and research 13 (2021)
Xi Sun, Shuning Ding, Shuangshuang Lu, Zheng Wang, Xiaosong Chen, Kunwei Shen
Identification of Ten Mitosis Genes Associated with Tamoxifen Resistance in Breast Cancer. OncoTargets and therapy 14 (2021)
Yifei Zhu, Tiange Wang, Jiayi Wu, Ou Huang, Li Zhu, Jianrong He, Yafen Li, Weiguo Chen, Xiaosong Chen, Kunwei Shen
Biomarkers of Insulin and the Insulin-Like Growth Factor Axis in Relation to Breast Cancer Risk in Chinese Women. OncoTargets and therapy 13 (2020)
Shuning Ding, Xiaosong Chen, Kunwei Shen
Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy. Cancer communications (London, England) 40 (8) (2020)
Weiqi Gao, Yufei Zeng, Xiaochun Fei, Xiaosong Chen, Kunwei Shen
Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a multi-institutional retrospective analysis. Breast cancer research and treatment 184 (1) (2020)
Qiong Fang, Jiahui Huang, Lu Gan, Kunwei Shen, Xiaosong Chen, Beiwen Wu
Weight Gain during Neoadjuvant Chemotherapy is Associated with Worse Outcome among the Patients with Operable Breast Cancer. Journal of breast cancer 22 (3) (2019)